涉及CYP3A4酶的二氢吡啶钙通道阻滞剂的药物相互作用

{"title":"涉及CYP3A4酶的二氢吡啶钙通道阻滞剂的药物相互作用","authors":"","doi":"10.13187/ejm.2019.2.106","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":50709,"journal":{"name":"Central European Journal of Medicine","volume":"307 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Drug Interactions of Dihydropyridine Calcium Channel Blockers (CCBs) involving CYP3A4 Enzymes\",\"authors\":\"\",\"doi\":\"10.13187/ejm.2019.2.106\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":50709,\"journal\":{\"name\":\"Central European Journal of Medicine\",\"volume\":\"307 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Central European Journal of Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.13187/ejm.2019.2.106\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Central European Journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13187/ejm.2019.2.106","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}